Policy options for sustainable access to off-patent antibiotics in Europe
Securing sustainable access to existing antibiotics optimises agent choice for individual treatments and is crucial to curb antibiotic resistance. …
Tag: Drug regulation
Insights into durability against resistance from the antibiotic nitrofurantoin
Nitrofurantoin has shown exceptional durability against resistance over 70 years of use. This longevity stems from factors such as rapid achievemen…
An Australian perspective on clinical, economic and regulatory considerations in emerging nanoparticle therapies for infections
Antimicrobial resistance (AMR) poses a growing global health threat. Nanomedicine, combined with drug repurposing, may help extend the effective li…